 | • レポートコード：QFJ1-5642 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、がん免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、免疫チェックポイント阻害剤、免疫系モジュレーター、癌ワクチン）、用途別市場規模（肺がん、乳がん、結腸直腸がん、黒色腫、前立腺がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・がん免疫療法の市場動向 ・企業の競争状況、市場シェア ・がん免疫療法の種類別市場規模と予測2016-2027（モノクローナル抗体、免疫チェックポイント阻害剤、免疫系モジュレーター、癌ワクチン） ・がん免疫療法の用途別市場規模と予測2016-2027（肺がん、乳がん、結腸直腸がん、黒色腫、前立腺がん、その他） ・がん免疫療法の北米市場規模2016-2027（アメリカ、カナダ） ・がん免疫療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん免疫療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん免疫療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん免疫療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、AstraZeneca、Roche、Bayer、Bristol-Myers Squibb、Eli Lilly、Merck、Novartis、Pfizer） ・結論 |
Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body’s natural defenses to fight cancer.
Market Analysis and Insights: Global Cancer Immunotherapy Market
The global Cancer Immunotherapy market size is projected to reach US$ 135140 million by 2027, from US$ 75950 million in 2020, at a CAGR of 8.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Immunotherapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Immunotherapy market.
Global Cancer Immunotherapy Scope and Market Size
Cancer Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Segment by Application
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
AstraZeneca
Roche
Bayer
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Immune System Modulators
1.2.5 Cancer Vaccines
1.3 Market by Application
1.3.1 Global Cancer Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Melanoma
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Immunotherapy Market Perspective (2016-2027)
2.2 Cancer Immunotherapy Growth Trends by Regions
2.2.1 Cancer Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Immunotherapy Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Immunotherapy Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Immunotherapy Industry Dynamic
2.3.1 Cancer Immunotherapy Market Trends
2.3.2 Cancer Immunotherapy Market Drivers
2.3.3 Cancer Immunotherapy Market Challenges
2.3.4 Cancer Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Immunotherapy Players by Revenue
3.1.1 Global Top Cancer Immunotherapy Players by Revenue (2016-2021)
3.1.2 Global Cancer Immunotherapy Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Immunotherapy Revenue
3.4 Global Cancer Immunotherapy Market Concentration Ratio
3.4.1 Global Cancer Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Revenue in 2020
3.5 Cancer Immunotherapy Key Players Head office and Area Served
3.6 Key Players Cancer Immunotherapy Product Solution and Service
3.7 Date of Enter into Cancer Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Immunotherapy Breakdown Data by Type
4.1 Global Cancer Immunotherapy Historic Market Size by Type (2016-2021)
4.2 Global Cancer Immunotherapy Forecasted Market Size by Type (2022-2027)
5 Cancer Immunotherapy Breakdown Data by Application
5.1 Global Cancer Immunotherapy Historic Market Size by Application (2016-2021)
5.2 Global Cancer Immunotherapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Immunotherapy Market Size (2016-2027)
6.2 North America Cancer Immunotherapy Market Size by Type
6.2.1 North America Cancer Immunotherapy Market Size by Type (2016-2021)
6.2.2 North America Cancer Immunotherapy Market Size by Type (2022-2027)
6.2.3 North America Cancer Immunotherapy Market Size by Type (2016-2027)
6.3 North America Cancer Immunotherapy Market Size by Application
6.3.1 North America Cancer Immunotherapy Market Size by Application (2016-2021)
6.3.2 North America Cancer Immunotherapy Market Size by Application (2022-2027)
6.3.3 North America Cancer Immunotherapy Market Size by Application (2016-2027)
6.4 North America Cancer Immunotherapy Market Size by Country
6.4.1 North America Cancer Immunotherapy Market Size by Country (2016-2021)
6.4.2 North America Cancer Immunotherapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cancer Immunotherapy Market Size (2016-2027)
7.2 Europe Cancer Immunotherapy Market Size by Type
7.2.1 Europe Cancer Immunotherapy Market Size by Type (2016-2021)
7.2.2 Europe Cancer Immunotherapy Market Size by Type (2022-2027)
7.2.3 Europe Cancer Immunotherapy Market Size by Type (2016-2027)
7.3 Europe Cancer Immunotherapy Market Size by Application
7.3.1 Europe Cancer Immunotherapy Market Size by Application (2016-2021)
7.3.2 Europe Cancer Immunotherapy Market Size by Application (2022-2027)
7.3.3 Europe Cancer Immunotherapy Market Size by Application (2016-2027)
7.4 Europe Cancer Immunotherapy Market Size by Country
7.4.1 Europe Cancer Immunotherapy Market Size by Country (2016-2021)
7.4.2 Europe Cancer Immunotherapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Immunotherapy Market Size (2016-2027)
8.2 Asia-Pacific Cancer Immunotherapy Market Size by Type
8.2.1 Asia-Pacific Cancer Immunotherapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Immunotherapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Immunotherapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Immunotherapy Market Size by Application
8.3.1 Asia-Pacific Cancer Immunotherapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Immunotherapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Immunotherapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Immunotherapy Market Size by Region
8.4.1 Asia-Pacific Cancer Immunotherapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Immunotherapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Immunotherapy Market Size (2016-2027)
9.2 Latin America Cancer Immunotherapy Market Size by Type
9.2.1 Latin America Cancer Immunotherapy Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Immunotherapy Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Immunotherapy Market Size by Type (2016-2027)
9.3 Latin America Cancer Immunotherapy Market Size by Application
9.3.1 Latin America Cancer Immunotherapy Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Immunotherapy Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Immunotherapy Market Size by Application (2016-2027)
9.4 Latin America Cancer Immunotherapy Market Size by Country
9.4.1 Latin America Cancer Immunotherapy Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Immunotherapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Immunotherapy Market Size (2016-2027)
10.2 Middle East & Africa Cancer Immunotherapy Market Size by Type
10.2.1 Middle East & Africa Cancer Immunotherapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Immunotherapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Immunotherapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Immunotherapy Market Size by Application
10.3.1 Middle East & Africa Cancer Immunotherapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Immunotherapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Immunotherapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Immunotherapy Market Size by Country
10.4.1 Middle East & Africa Cancer Immunotherapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Immunotherapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Immunotherapy Introduction
11.1.4 Amgen Revenue in Cancer Immunotherapy Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cancer Immunotherapy Introduction
11.2.4 AstraZeneca Revenue in Cancer Immunotherapy Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Cancer Immunotherapy Introduction
11.3.4 Roche Revenue in Cancer Immunotherapy Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Cancer Immunotherapy Introduction
11.4.4 Bayer Revenue in Cancer Immunotherapy Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Cancer Immunotherapy Introduction
11.5.4 Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Cancer Immunotherapy Introduction
11.6.4 Eli Lilly Revenue in Cancer Immunotherapy Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Cancer Immunotherapy Introduction
11.7.4 Merck Revenue in Cancer Immunotherapy Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Cancer Immunotherapy Introduction
11.8.4 Novartis Revenue in Cancer Immunotherapy Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Cancer Immunotherapy Introduction
11.9.4 Pfizer Revenue in Cancer Immunotherapy Business (2016-2021)
11.9.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Immune Checkpoint Inhibitors
Table 4. Key Players of Immune System Modulators
Table 5. Key Players of Cancer Vaccines
Table 6. Global Cancer Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Immunotherapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cancer Immunotherapy Market Share by Regions (2016-2021)
Table 10. Global Cancer Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cancer Immunotherapy Market Share by Regions (2022-2027)
Table 12. Cancer Immunotherapy Market Trends
Table 13. Cancer Immunotherapy Market Drivers
Table 14. Cancer Immunotherapy Market Challenges
Table 15. Cancer Immunotherapy Market Restraints
Table 16. Global Cancer Immunotherapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cancer Immunotherapy Market Share by Players (2016-2021)
Table 18. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy as of 2020)
Table 19. Ranking of Global Top Cancer Immunotherapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cancer Immunotherapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Immunotherapy Product Solution and Service
Table 23. Date of Enter into Cancer Immunotherapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cancer Immunotherapy Revenue Market Share by Type (2016-2021)
Table 27. Global Cancer Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cancer Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cancer Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cancer Immunotherapy Revenue Market Share by Application (2016-2021)
Table 31. Global Cancer Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cancer Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cancer Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cancer Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cancer Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cancer Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cancer Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cancer Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cancer Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cancer Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cancer Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cancer Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cancer Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cancer Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer Immunotherapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cancer Immunotherapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cancer Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cancer Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cancer Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cancer Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cancer Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen Company Details
Table 64. Amgen Business Overview
Table 65. Amgen Cancer Immunotherapy Product
Table 66. Amgen Revenue in Cancer Immunotherapy Business (2016-2021) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Cancer Immunotherapy Product
Table 71. AstraZeneca Revenue in Cancer Immunotherapy Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Cancer Immunotherapy Product
Table 76. Roche Revenue in Cancer Immunotherapy Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Cancer Immunotherapy Product
Table 81. Bayer Revenue in Cancer Immunotherapy Business (2016-2021) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Bristol-Myers Squibb Company Details
Table 84. Bristol-Myers Squibb Business Overview
Table 85. Bristol-Myers Squibb Cancer Immunotherapy Product
Table 86. Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2016-2021) & (US$ Million)
Table 87. Bristol-Myers Squibb Recent Development
Table 88. Eli Lilly Company Details
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Cancer Immunotherapy Product
Table 91. Eli Lilly Revenue in Cancer Immunotherapy Business (2016-2021) & (US$ Million)
Table 92. Eli Lilly Recent Development
Table 93. Merck Company Details
Table 94. Merck Business Overview
Table 95. Merck Cancer Immunotherapy Product
Table 96. Merck Revenue in Cancer Immunotherapy Business (2016-2021) & (US$ Million)
Table 97. Merck Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Revenue in Cancer Immunotherapy Business (2016-2021) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Cancer Immunotherapy Product
Table 105. Pfizer Revenue in Cancer Immunotherapy Business (2016-2021) & (US$ Million)
Table 106. Pfizer Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Immunotherapy Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Immune Checkpoint Inhibitors Features
Figure 4. Immune System Modulators Features
Figure 5. Cancer Vaccines Features
Figure 6. Global Cancer Immunotherapy Market Share by Application: 2020 VS 2027
Figure 7. Lung Cancer Case Studies
Figure 8. Breast Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Cancer Immunotherapy Report Years Considered
Figure 14. Global Cancer Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Cancer Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Cancer Immunotherapy Market Share by Regions: 2020 VS 2027
Figure 17. Global Cancer Immunotherapy Market Share by Regions (2022-2027)
Figure 18. Global Cancer Immunotherapy Market Share by Players in 2020
Figure 19. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Revenue in 2020
Figure 21. Global Cancer Immunotherapy Revenue Market Share by Type (2016-2021)
Figure 22. Global Cancer Immunotherapy Revenue Market Share by Type (2022-2027)
Figure 23. North America Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Cancer Immunotherapy Market Share by Type (2016-2027)
Figure 25. North America Cancer Immunotherapy Market Share by Application (2016-2027)
Figure 26. North America Cancer Immunotherapy Market Share by Country (2016-2027)
Figure 27. United States Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Cancer Immunotherapy Market Share by Type (2016-2027)
Figure 31. Europe Cancer Immunotherapy Market Share by Application (2016-2027)
Figure 32. Europe Cancer Immunotherapy Market Share by Country (2016-2027)
Figure 33. Germany Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Cancer Immunotherapy Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Cancer Immunotherapy Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Cancer Immunotherapy Market Share by Region (2016-2027)
Figure 43. China Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Cancer Immunotherapy Market Share by Type (2016-2027)
Figure 51. Latin America Cancer Immunotherapy Market Share by Application (2016-2027)
Figure 52. Latin America Cancer Immunotherapy Market Share by Country (2016-2027)
Figure 53. Mexico Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Cancer Immunotherapy Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Cancer Immunotherapy Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Cancer Immunotherapy Market Share by Country (2016-2027)
Figure 59. Turkey Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Cancer Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Amgen Revenue Growth Rate in Cancer Immunotherapy Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Cancer Immunotherapy Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Cancer Immunotherapy Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Cancer Immunotherapy Business (2016-2021)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Cancer Immunotherapy Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Cancer Immunotherapy Business (2016-2021)
Figure 68. Merck Revenue Growth Rate in Cancer Immunotherapy Business (2016-2021)
Figure 69. Novartis Revenue Growth Rate in Cancer Immunotherapy Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Cancer Immunotherapy Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の前立腺がん市場規模・現状・予測（2021年-2027年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in a…- 世界の血液がん遺伝子改変免疫療法市場規模・現状・予測（2021年-2027年） Genetic modification immunotherapy for blood cancer is a technique that involves genetic modification of immune system T cells.It allows T cells to recognize weakly expressed antigens in the blood or other organs of the body, such as tumor cells.This form of immunotherapy can be divided into two typ…
- 世界の個別化がんワクチン市場規模・現状・予測（2021年-2027年） Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells…
- 世界の樹状細胞癌ワクチン免疫療法市場規模・現状・予測（2021年-2027年） Dendritic cells (DCs) are one of the major antigen-presenting cells found in lymphoid organs. Main function of the dendritic cells is antigen display and activation of T-cells. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. These …
- 世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年） Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC. Market Analysis and Insights: Global Cast…